Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04689347
Status:
UNKNOWN
Last Update Posted:
2022-04-04
First Post:
2020-12-22
Brief Title:
5FULV Irinotecan Temozolomide and Bevacizumab for MGMT Silenced Microsatellite Stable Metastatic Colorectal Cancer
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Organization:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Organization Data
Organization:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Class:
OTHER
Study ID:
INT 15120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None